Incorporating PARP Inhibition in Cancer Therapy: Key Questions, Expert Answers

This engaging symposium focussed on the rationale and current evidence supporting the role for poly(adenosine diphosphate-ribose) polymerase (PARP) inhibition in patients with cancer. The meeting opened with an overview of DNA repair and the biological basis for targeting this process in oncology, d...

Full description

Bibliographic Details
Main Authors: Tristin Abair, Hilary Calvert, Nicoletta Colombo, Eric Pujade-Lauraine, Andrew Tutt, Eric Van Cutsem
Format: Article
Language:English
Published: European Medical Journal 2015-11-01
Series:European Medical Journal Oncology
Subjects:
ECC
Online Access:http://emjreviews.com/wp-content/uploads/Incorporating-PARP-Inhibition-in-Cancer-Therapy-Key-Questions-Expert-Answers.pdf

Similar Items